Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A11QVV0
Fri, 05.05.2023       Heidelberg Pharma AG
DE000A11QVV0

PRESS RELEASE Heidelberg Pharma appoints Chief Financial Officer Ladenburg, Germany, 5 May 2023 – Heidelberg Pharma AG (FSE: HPHA) today announced that Walter Miller has been appointed Chief Financial Officer effective 1st May 2023. Dr. Jan Schmidt-Brand, who has served in a dual role since 2014, will remain Spokesman of the Management Board/CEO  [ … ]
Technical analysis
To the publication
Fri, 05.05.2023       Heidelberg Pharma AG
DE000A11QVV0

PRESS RELEASE Heidelberg Pharma appoints Chief Financial Officer Ladenburg, Germany, 5 May 2023 – Heidelberg Pharma AG (FSE: HPHA) today announced that Walter Miller has been appointed Chief Financial Officer effective 1st May 2023. Dr. Jan Schmidt-Brand, who has served in a dual role since 2014, will remain Spokesman of the Management Board/CEO  [ … ]
Technical analysis
To the publication
Thu, 13.04.2023       Heidelberg Pharma AG
DE000A11QVV0

Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2023 Initial findings of HDP-101 presented at ASH Annual Meeting Signing of a partnership with Binghamton University Termination agreement signed with Magenta Financials in line with planning Ladenburg, Germany, 4 April 2023 - Heidelberg Pharma AG (FSE: HPHA) today [ … ]
Technical analysis
To the publication
Thu, 13.04.2023       Heidelberg Pharma AG
DE000A11QVV0

Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2023 Initial findings of HDP-101 presented at ASH Annual Meeting Signing of a partnership with Binghamton University Termination agreement signed with Magenta Financials in line with planning Ladenburg, Germany, 4 April 2023 - Heidelberg Pharma AG (FSE: HPHA) today [ … ]
Technical analysis
To the publication
Tue, 04.04.2023       Heidelberg Pharma AG
DE000A11QVV0

PRESS RELEASE Heidelberg Pharma Presents New Preclinical Data from its Proprietary ATAC Technology Platform at AACR Annual Meeting 2023 Ladenburg, Germany, 4th April 2023 – Heidelberg Pharma AG (FSE: HPHA) will present data from preclinical studies at this year's American Association for Cancer Research (AACR) annual meeting that provide positive [ … ]
Technical analysis
To the publication
Tue, 04.04.2023       Heidelberg Pharma AG
DE000A11QVV0

PRESS RELEASE Heidelberg Pharma Presents New Preclinical Data from its Proprietary ATAC Technology Platform at AACR Annual Meeting 2023 Ladenburg, Germany, 4th April 2023 – Heidelberg Pharma AG (FSE: HPHA) will present data from preclinical studies at this year's American Association for Cancer Research (AACR) annual meeting that provide positive [ … ]
Technical analysis
To the publication
Fri, 24.03.2023       Heidelberg Pharma AG
DE000A11QVV0

PRESS RELEASE Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business Start of clinical trial and first safety data with HDP-101 in multiple myeloma Conclusion and implementation of a strategic partnership with Huadong Medicine Successful financing activities Financials in line with adjusted guidance  [ … ]
Technical analysis
To the publication
Fri, 24.03.2023       Heidelberg Pharma AG
DE000A11QVV0

PRESS RELEASE Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business Start of clinical trial and first safety data with HDP-101 in multiple myeloma Conclusion and implementation of a strategic partnership with Huadong Medicine Successful financing activities Financials in line with adjusted guidance  [ … ]
Technical analysis
To the publication
Fri, 16.12.2022       Heidelberg Pharma AG
DE000A11QVV0

PRESS RELEASE Heidelberg Pharma Signs Research and Exclusive Option Agreement with Binghamton University on Immunostimulatory Technology Platform Ladenburg, Germany, 16 December 2022 – Heidelberg Pharma AG (FSE: HPHA) today announced that it has entered into a research and exclusive option agreement with Binghamton University, State University of [ … ]
Technical analysis
To the publication
Fri, 16.12.2022       Heidelberg Pharma AG
DE000A11QVV0

PRESS RELEASE Heidelberg Pharma Signs Research and Exclusive Option Agreement with Binghamton University on Immunostimulatory Technology Platform Ladenburg, Germany, 16 December 2022 – Heidelberg Pharma AG (FSE: HPHA) today announced that it has entered into a research and exclusive option agreement with Binghamton University, State University of [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Thursday, 04.07.2024, Calendar Week 27, 186th day of the year, 180 days remaining until EoY.